Avatrombopag OverviewAvatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure. It was approved for medical use in the United States in 2018, and in the European Union in 2019. References ^ "FDA approves new drug for patients with chronic...
Read more Avatrombopag Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Avatrombopag
Recent Avatrombopag Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 20mg
Other drugs which contain Avatrombopag or a similar ingredient: (1 result)
- DOPTELET Avatrombopag Maleate